AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) is set to participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, Sept. 4, 2024, at 9:15 a.m. ET. Robert A. Bradway, Amgen's chairman and CEO, will be presenting at the event.

The presentation will be webcast live and made available to the public, media, and investors. Interested parties can access the webcast through Amgen's website (www.amgen.com) under the Investors section. The company's Investor Relations Events Calendar provides details on presentation times and webcast links.

This webcast, along with other selected presentations on Amgen's business developments, will be archived and available for replay for at least 90 days after the event.

THOUSAND OAKS, Calif., Aug. 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 22^nd Annual Global Healthcare Conference at 9:15 a.m. ET on Wednesday, Sept. 4, 2024. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 

CONTACT: Amgen, Thousand Oaks 
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference-302234174.html

SOURCE Amgen

FAQ

When is Amgen (AMGN) presenting at the Morgan Stanley Global Healthcare Conference?

Amgen (AMGN) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 9:15 a.m. ET.

Who will be presenting for Amgen (AMGN) at the Morgan Stanley conference?

Robert A. Bradway, chairman and chief executive officer of Amgen (AMGN), will be presenting at the Morgan Stanley conference.

How can I watch Amgen's (AMGN) presentation at the Morgan Stanley conference?

You can watch Amgen's (AMGN) presentation via a live webcast on the company's website, www.amgen.com, under the Investors section.

How long will Amgen's (AMGN) Morgan Stanley conference presentation be available for replay?

Amgen's (AMGN) presentation at the Morgan Stanley conference will be archived and available for replay for at least 90 days after the event.